HuGE Literature Finder
Records
1
-
30
| Genetic contributions of MHC class I antigen processing and presentation pathway to bladder cancer risk and recurrence. Neoplasma 2022 Jan . Wieczorek Edyta, Jablonowski Zbigniew, Lesicka Monika, Jablonska Ewa, Kutwin Piotr, Reszka Edyta, Garstka Malgorzata An |
| Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer. Journal of translational medicine 2022 8 20 (1): 362. Shi Jian, Wang Li, Yin Xiangzhe, Wang Lixia, Bo Lin, Liu Kailai, Feng Ke, Lin Shihua, Xu Yanjun, Ning Shangwei, Zhao Hongyi |
| Involvement of inflammatory cytokines and epigenetic modification of the mtTFA complex in T-helper cells of patients' suffering from non-small cell lung cancer and chronic obstructive pulmonary disease. Molecular immunology 2022 9 151 70-83. Shanmugam Geetha, Sunny Jithin S, Rakshit Sudeshna, George Melvin, Leela K V, Sarkar Koust |
| Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma. Frontiers in immunology 2022 5 13 840811. Wang Tiantian, Shi Jinyuan, Li Luchuan, Zhou Xiaoming, Zhang Hui, Zhang Xiaofang, Wang Yong, Liu Lian, Sheng L |
| Polymorphisms and haplotypes of IL2RA, IL10, IFNG, IRF5, and CCR2 are associated with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children. Pediatric blood & cancer 2021 May e29097. Tang Nannan, Huang Junbin, Chen Chun, Wu Xiaojun, Xu Honggui, Chen Guohua, Xue Hongm |
| Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy. Frontiers in genetics 2021 12 646362. Cheng Tianli, Zhang Jing, Liu Danni, Lai Guorong, Wen Xiaopi |
| Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma. Frontiers in medicine 2021 8 755657. Wen Fang, Ruan Shuai, Huang Wenjie, Chen Xiaoxue, Wang Yulan, Gu Suping, Liu Jiatong, Liu Shenlin, Shu Pe |
| RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma. Frontiers in oncology 2021 11 677826. Liu Bing, Wang Yaqi, Wang Han, Li Zhongwu, Yang Lujing, Yan Shi, Yang Xin, Ma Yuanyuan, Gao Xuan, Guan Yanfang, Yi Xin, Xia Xuefeng, Li Jingjing, Wu N |
| Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients. Cancer science 2020 6 111 (8): 3057-3070. Hiraoka Nobuyoshi, Ino Yoshinori, Hori Shutaro, Yamazaki-Itoh Rie, Naito Chie, Shimasaki Mari, Esaki Minoru, Nara Satoshi, Kishi Yoji, Shimada Kazuaki, Nakamura Naoya, Torigoe Toshihiko, Heike Yu |
| SNPs in the interleukin-12 signaling pathway are associated with breast cancer risk in Puerto Rican women. Oncotarget 2020 9 11 (37): 3420-3431. Núñez-Marrero Angel, Arroyo Nelly, Godoy Lenin, Rahman Mohammad Zillur, Matta Jaime L, Dutil Jul |
| Individual Genetic Variation Might Predict Acute Skin Reactions in Women Undergoing Adjuvant Breast Cancer Radiotherapy. Anticancer research 2018 Dec 38 (12): 6763-6770. Oliva Delmy, Nilsson Mats, Strandéus Michael, Andersson Bengt-Åke, Sharp Lena, Laytragoon-Lewin Nongnit, Lewin Fred |
| Genetic variations in the SULF1 gene alter the risk of cervical cancer and precancerous lesions. Oncology letters 2018 Sep 16 (3): 3833-3841. Dardiotis Efthimios, Siokas Vasileios, Garas Antonios, Paraskevaidis Evangelos, Kyrgiou Maria, Xiromerisiou Georgia, Deligeoroglou Efthimios, Galazios Georgios, Kontomanolis Emmanuel N, Spandidos Demetrios A, Tsatsakis Aristidis, Daponte Alexandr |
| IFNG +874 A/T is associated with acute lymphoblastic leukemia in Mexican Mestizos. Cytokine 2018 Sep 111 265-271. González-Quezada Betsy Annel, Flores-Aguilar Hilario, Olaya-Vargas Alberto, Salazar-Rosales Haydee, Pérez-García Martín, Valero-Saldaña Luis Manuel, Acosta-Maldonado Brenda Lizeth, Ovilla-Martínez Roberto, Gorodezky Cla |
| Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Feb . Eaton Keith D, Romine Perrin E, Goodman Gary E, Thornquist Mark D, Barnett Matt J, Petersdorf Effie |
| A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy. Frontiers in pharmacology 2018 10 9 1101. De Mattia Elena, Dreussi Eva, Montico Marcella, Gagno Sara, Zanusso Chiara, Quartuccio Luca, De Vita Salvatore, Guardascione Michela, Buonadonna Angela, D'Andrea Mario, Pella Nicoletta, Favaretto Adolfo, Mini Enrico, Nobili Stefania, Romanato Loredana, Cecchin Erika, Toffoli Giusep |
| BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer. Oncotarget 2018 5 9 (25): 17501-17511. Wieser Verena, Gaugg Inge, Fleischer Martina, Shivalingaiah Giridhar, Wenzel Soeren, Sprung Susanne, Lax Sigurd F, Zeimet Alain G, Fiegl Heidelinde, Marth Christi |
| Increased CD4 T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients. Clinical epigenetics 2018 8 10 (1): 102. Ahlén Bergman Emma, Hartana Ciputra Adijaya, Johansson Markus, Linton Ludvig B, Berglund Sofia, Hyllienmark Martin, Lundgren Christian, Holmström Benny, Palmqvist Karin, Hansson Johan, Alamdari Farhood, Huge Ylva, Aljabery Firas, Riklund Katrine, Winerdal Malin E, Krantz David, Zirakzadeh A Ali, Marits Per, Sjöholm Louise K, Sherif Amir, Winqvist O |
| Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses. American journal of translational research 2018 10 (6): 1677-1689. Jin Zining, Xu Lu, Zhang Lei, Zhao Min, Li Dongbao, Ye Lijun, Ma Ying, Ren Siyu, Yu Hailan, Wang Danyu, Liang Chunyan, Chen |
| Clinical significance of YAP1 activation in head and neck squamous cell carcinoma. Oncotarget 2017 Dec 8 (67): 111130-111143. Eun Young-Gyu, Lee Dongjin, Lee Young Chan, Sohn Bo Hwa, Kim Eui Hyun, Yim Sun Young, Kwon Kee Hwan, Lee Ju-Se |
| Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. The Prostate 2017 Mar . Winchester Danyelle A, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Santella Regina M, Johnson-Pais Teresa L, Leach Robin J, Xu Jianfeng, Zheng S Lilly, Thompson Ian M, Lucia M Scott, Lippman Scott M, Parnes Howard L, Isaacs William B, De Marzo Angelo M, Drake Charles G, Platz Elizabeth |
| Note of clarification of data in the paper entitled "Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis". Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 04 39 (4): 1010428317694564. Yang Haijun, Yang Min, Wang Yan, Huang Xi |
| Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial. The Prostate 2016 Jan . Winchester Danyelle A, Gurel Bora, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Santella Regina M, Johnson-Pais Teresa L, Leach Robin J, Thompson Ian M, Xu Jianfeng, Zheng S Lilly, Lucia M Scott, Lippman Scott M, Parnes Howard L, Isaacs William B, Drake Charles G, Marzo Angelo M De, Platz Elizabeth |
| Integrated genomic analysis of survival outliers in glioblastoma. Neuro-oncology 2016 12 19 (6): 833-844. Peng Sen, Dhruv Harshil, Armstrong Brock, Salhia Bodour, Legendre Christophe, Kiefer Jeffrey, Parks Julianna, Virk Selene, Sloan Andrew E, Ostrom Quinn T, Barnholtz-Sloan Jill S, Tran Nhan L, Berens Michael |
| Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study. BMC cancer 2016 16 (1): 330. Torres-Poveda K, Burguete-García A I, Bahena-Román M, Méndez-Martínez R, Zurita-Díaz M A, López-Estrada G, Delgado-Romero K, Peralta-Zaragoza O, Bermúdez-Morales V H, Cantú D, García-Carrancá A, Madrid-Marina |
| Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial. The Prostate 2015 Sep 75 (13): 1403-18. Winchester Danyelle A, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Santella Regina M, Johnson-Pais Teresa L, Leach Robin J, Xu Jianfeng, Zheng S Lilly, Thompson Ian M, Lucia M Scott, Lippmann Scott M, Parnes Howard L, Dluzniewski Paul J, Isaacs William B, De Marzo Angelo M, Drake Charles G, Platz Elizabeth |
| Polymorphisms in immune mediators associate with risk of cervical cancer. Gynecologic oncology 2014 Oct 135 (1): 69-73. Zhang Zhengyan, Fye Samantha, Borecki Ingrid B, Rader Janet |
| Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jul 35 (7): 6405-14. Ge Yu-Zheng, Wang Yi-Dan, Xu Zheng, Xu Lu-Wei, Wang Ya-Ping, Gu Mao-Hong, Ding Ai-Xing, Zhu Xian-Bo, Wu Ran, Li Wen-Cheng, Xu You-Di, Jia Rui-Pe |
| Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance. British journal of cancer 2014 9 111 (8): 1581-9. Ganapathi S K, Beggs A D, Hodgson S V, Kumar |
| Interleukin genes and associations with colon and rectal cancer risk and overall survival. International journal of cancer. Journal international du cancer 2013 Feb 132 (4): 905-15. Bondurant Kristina L, Lundgreen Abbie, Herrick Jennifer S, Kadlubar Susan, Wolff Roger K, Slattery Martha |
| Downregulation of IFNG in CD4(+) T cells in lung cancer through hypermethylation: a possible mechanism of tumor-induced immunosuppression. PloS one 2013 11 8 (11): e79064. Wang Fang, Xu Jian, Zhu Quan, Qin Xuejun, Cao Yan, Lou Jiangfang, Xu Yuqiao, Ke Xing, Li Qing, Xie Erfu, Zhang Lixia, Sun Ruihong, Chen Liang, Fang Bingliang, Pan Shiya |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: